BPH SOLUTION

GAMMES & PRODUITS

CATALOGUE PRODUITS

NEWSLETTER

EchoLaser®

TPLA™

Transperineal Laser Ablation

A unique Micro-Invasive Ultrasound guided BPH Solution*

*Echolaser x4 is FDA cleared for Soft Tissue Ablation in Urology

APPLICATION

EchoLaser is used in case of patients suffering from Benign Prostatic Hyperplasia (BPH), with lower urinary tract symptoms.

WHAT IS ECHOLASER?

Micro- Invasive technique with fine needles:
EchoLaser TPLA™ uses the laser light to heat the tissue to be treated until irreversible in-situ damage occurs.
Very fine needles (21G) are inserted via transperineal access without touching the urethra, for a treatment a-traumatic and very well tolerated by the patient.
Real-time monitoring of the treatment It can be performed under ultrasound
guidance for real-time monitoring of the correct positioning of the laser light applicators.

BENEFITS

EchoLaser

• Ejaculation preservation (96%)
• Erectile function preservation
• Continence preservation

• Micro-invasive approach (thanks to the extremely fine needles)
• No need for a general anaesthesia
• Also suitable for high-risk patients
• Short duration of treatment (few minutes)

• No or reduced post-op pain
• No or reduced hospitalisation
• Fast recovery times

MAIN BIBLIOGRAPHY

• Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project.
Cocci A et al.
Asian Journal of Urology, 2023, ISSN 2214-3882, https://doi. org/10.1016/j.ajur.2023.07.001.

• Three years outcomes of transperineal laser ablation of the prostate.
Minafra P, DE Rienzo G, Gerbasi S, Cindolo L, Battaglia M, Ditonno P.
Minerva Urol Nephrol. 2023 Jun 14. doi: 10.23736/S2724- 6051.23.05270-9. Epub ahead of print. PMID: 37314812.

• Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies.
Tafuri A, Panunzio A, De Carlo F, Luperto E, Di Cosmo F, Cavaliere A, Rizzo M, Tian Z, Shakir A, De Mitri R, Porcaro AB, Cerruto MA, Antonelli A, Cormio L, Carrieri G, Karakiewicz PI, Abreu AL, Pagliarulo V.
J Clin Med. 2023 Feb 26;12(5):1860. doi: 10.3390/jcm12051860. PMID: 36902647; PMCID: PMC10003190.

• Ejaculatory Function following Transperineal Laser Ablation versus TURP for Benign Prostatic Obstruction: A Randomized Trial.
Bertolo R, Iacovelli V, Cipriani C, Carilli M, Vittori M, Antonucci M, Maiorino F, Signoretti M, Petta F, Travaglia S, Panei M, Bove P.
BJU Int. 2023 Mar 14. doi: 10.1111/bju.16008. PMID: 36917033.

• Trans-Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction.
Destefanis P, Sibona M, Vitiello F, Vercelli E, Micai L, Montefusco G, Mangione C, Bracco F, Colucci F, De Nunzio C, Gontero P.
Prostate Cancer Prostatic Dis (2023). https://doi.org/10.1038/s41391-023-00736-5

• Office-Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia Under Local Anesthesia: 2-Year Results from a Dose Range Confirmatory Trial.
Bianco FJ, Luna E, Lopez-Prieto A, González P, Gheiler EL, Kaufman AM, Avila L, Maiolino G.
JU Open Plus 2(2):e00007, February 2024. | DOI: 10.1097/JU9.0000000000000105.

ECHOLASER® TPLA™ PROCEDURE

Before the procedure

• Position the patient in gynecological position

• Insert a bladder catheter to visualize the urethra

• Measurement of the prostate volume

• Transperineal local anesthesia (skin + periprostatic block)

Needle insertion with transperineal approach

• Definition of the positioning strategy for needles and fibers with ESI (EchoLaser Smart Interface) based on the morphology of the prostate

Insertion of the needles: one or two 21G introducer needles for each lobe, according to the prostate dimensions and shape

• Removal of the inner part of the needle to allow the fiber insertion

Fiber Insertion

• Insert the 300-μm optical laser fiber into each needle

• Check safety distance of the fibers from the surrounding anatomical structures
and verify it with ESI

• Energy supply (5-10 min)

• Pull-back : if necessary based on the volume of the adenoma (5-10 min)

• Removal the needles + fibres

Patient discharged

Usually the same day of the procedure.

ECHOLASER® VIDÉO

SYSTEM COMPONENTS

Multi-needle guiding systems

Disposable fiber optics kit

• Fiber Optic
• Chiba Introduce

ECHOLASER® REFERENCES

EchoLaser®

ReferenceEchoLaser® systemQuantity / box
MEL01EchoLaser®1
ReferenceEchoLaser® Fiber KitsQuantity / box
ROEL_KITX20EchoLaser®20
EchoLaser® and TPLA™ are trademarks owned by Elesta
Products Specifications are subject to change without notice.
Please consult product label and insert for any indications, contraindications, hazards, warnings, cautions and directions for use.
For the latest information, always check the “Instructions for Use” that comes packaged with the product.
   Flyer